VLA(2) integrin expression in breast carcinomas evaluated by automated and quantitative immunohistochemistry

Hôpital Européen, Marseille, Marsiglia, Provence-Alpes-Côte d'Azur, France
British Journal of Cancer (Impact Factor: 4.84). 06/1998; 77(12):2274-80. DOI: 10.1038/bjc.1998.378
Source: PubMed


VLA2 is thought to be involved in the metastatic process in malignant tumours, in particular in carcinomatous cell adhesion to vessel basement membrane. VLA2 expression was immunohistochemically investigated in 204 breast carcinomas. Frozen tissue sections were probed with monoclonal anti-VLA2 using automated (Ventana ES 320 System) and quantitative (SAMBA 2005 image processor) immunoperoxidase. A positive anti-VLA2 immunoreaction was observed in 48 tumours (23.5%), within epithelial carcinomatous cells. The VLA2-positive surface in tumours varied from 3% to 20% (mean 8.75, S.D. 7.17) and was correlated with histoprognostic indicators and tumour expression of various antigens detected using the same method as that for VLA2. The results show that VLA2 immunoexpression was independent of the tumour size, grade, type and aneuploidy, and of the nodal status. VLA2 significantly correlated with ELAM, VCAM, VLA3 and P-glycoprotein (P-gp) (P < 0.01) and inversely correlated with cathepsin D (P < 0.001), but was independent of Ki67/MIB1, p53, bcl-2, c-erbB-2, E cadherin, CD44v, CD31, oestrogen and progesterone receptors' (ER, PR) antigenic sites and pS2. The exact role, if any, of VLA2 in tumour cell dissemination remains to be elucidated and the clinical relevance of VLA2 immunodetection in breast carcinomas requires further investigation of the correlation between VLA2 immunocytochemical expression and patients' outcome and response to chemotherapy.


Figure 1

Figure 2

Figure 3

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Progression of head and neck cancer is always associated with changes of gene expression profile. In this study, we characterized the expression of multidrug-resistance mdr1 gene, which may play a role in tumorigenesis and multidrug resistance in head and neck cancer. A TaqMan one-step RT-PCR with a linear range for quantification across at least a 5 log scale of concentration of mdr1 mRNA was designed to determine the level of mdr1 expression in 50 pairs of normal vs. malignant head and neck tissues. Both the absolute level of mdr1 mRNA in tumor (T) and the relative mdr1 expression between tumor and its normal counterpart (T/N) were measured and their associations with several clinical variables were analyzed. Among the clinical variables analyzed, only the clinical stage of tumor was found to be associated with mdr1 expression. The distribution of clinical stages differed significantly (P<0.01) among the 27 specimens that had a T/N>1, with 59.3%, 22.2%, 14.8% and 3.7% in stage IV, III, II, and I, respectively. In addition, 76% of stage IV and 75% of stage III tumors had a T/N>1 compared to 25% of stage II and 20% of stage I tumors (P=0.004). Multivariate logistic regression analysis also indicated a significant difference of mdr1 expression between the early (I and II) and advanced (III and IV) stages tumors. The adjusted odds ratios (95% confidence intervals) were 1.477 (1.084 - 2.012) and 1.001 (1.000-1.002) for T/N (P<0.05) and T (P<0.05) treated as continuous variables, and 15.521 (3.414-70.550) and 5.074 (1.154-22.311) for T/N (P<0.001) and T (P<0.05) treated as binary variables, respectively. Taken together, the data presented here indicated that real-time RT-PCR provides a quantitative way to monitor mdr1 gene expression. The differential expression of mdr1 between early and advanced stages of head and neck cancer may shed light on the process of tumorigenicity and offer clues to the planning of new treatments.
    Full-text · Article · Dec 2002 · Japanese journal of cancer research: Gann
  • [Show abstract] [Hide abstract]
    ABSTRACT: The possibility that a sinusoidal 50 Hz magnetic field with a magnetic flux density of 0.5 mT can induce variations in the expression of cell adhesion molecules (CAMs) in two human osteosarcoma cell lines (MG-63 and Saos-2) was investigated. In particular, the expression of two important integrins, VLA-2, the receptor for collagen, and VLA-5, the receptor for fibronectin, as well as CD44, were examined in both cell lines after these had been exposed for 7 and 14 days to a 50 Hz, 0.5 mT field. Cell surface morphology (scanning electron microscopy), cell growth characteristics (growth curves and cell cycle phase distribution), and cell death (necrosis and apoptosis) were also examined. The results demonstrate that no variations in surface morphology and cell death occurred between control and exposed cells in both MG-63 and Saos-2 cells, while significant changes were noted in cell growth and fibronectin and CD44 expression in MG-63 cells. The results are discussed in view of the important role that CAMs play in controlling various cancer cell functions, particularly proliferation and metastasis.
    No preview · Article · Jul 2003 · Bioelectromagnetics
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patients with systemic sclerosis (SSc) show, in addition to tissue fibrosis, a variety of distinct vascular and immunological abnormalities. Extracellular matrix proteins (ECM) play an important role in the regulation of cell migration and expression of various genes involved in activation of immune reactions. The aim of our study was to examine the co-stimulatory effects of ECM components (type I and IV collagen, laminin, fibronectin) in patients with SSc and to examine the expression of beta 1-integrins (VLA-2/CD49b, VLA-3/CD49c and VLA-5/CD49e) on PBMC in these patients. We examined 66 patients with various types of SSc and 62 healthy volunteers. The results showed that fibronectin and type I collagen had the highest co-stimulatory activities in both SSc patients and controls, whereas laminin and type IV collagen were less potent co-stimulatory agents. Flow cytometry data showed an increased expression of integrins (VLA-2, VLA-3, VLA-5) in SSc T-cells in comparison to healthy volunteers. The results of the proliferation assays in patients with SSc and normal volunteers showed that only fibronectin stimulated CD3--dependent lymphocyte response. Fibronectin co-stimulated T-cell proliferation in patients with SSc which may be dependent on increased expression of integrins CD49c or CD49e or/and level of circulating T-cells bearing these markers. Increasing of the expression of integrins on PBMC can help their migration to the perivascular spaces and can stimulate them. Fibronectin could enhance activation of PBMC followed by production of some cytokines involved in fibrosis in SSc.
    No preview · Article · Aug 2003 · Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego
Show more